Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-002401

Chief Operating Officer sold 2,629 shares at $15.17 ($39,882)

  • Chief Operating Officer acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Champoux Jennifer · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Grant or award : show line 1 in the form +35,000 65,000 D
2026-01-05 Sale : show line 2 in the form −2,629 $15.17 $39,882 62,371 D
Open-market sales · 2,629 sh · avg $15.17 · $39,882

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 3 in the form Stock Option (Right to Buy) +158,000 158,000 D
Loading xslF345X05/ownership.xml…